These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11417115)

  • 1. Current and potential therapies for the treatment of herpesvirus infections.
    Villarreal EC
    Prog Drug Res; 2001; 56():77-120. PubMed ID: 11417115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and potential therapies for the treatment of herpes-virus infections.
    Villarreal EC
    Prog Drug Res; 2003; 60():263-307. PubMed ID: 12790345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and potential therapies for the treatment of herpesvirus infections.
    Villarreal EC
    Prog Drug Res; 2001; Spec No():185-228. PubMed ID: 11548208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral drug resistance in herpesviruses other than cytomegalovirus.
    Piret J; Boivin G
    Rev Med Virol; 2014 May; 24(3):186-218. PubMed ID: 24604770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms.
    Gilbert C; Bestman-Smith J; Boivin G
    Drug Resist Updat; 2002 Apr; 5(2):88-114. PubMed ID: 12135584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    Tan HH; Goh CL
    Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.
    De Clercq E; Naesens L; De Bolle L; Schols D; Zhang Y; Neyts J
    Rev Med Virol; 2001; 11(6):381-95. PubMed ID: 11747000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging therapies for herpes viral infections (types 1 - 8).
    Chakrabarty A; Pang KR; Wu JJ; Narvaez J; Rauser M; Huang DB; Beutner KR; Tyring SK
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):237-56. PubMed ID: 15571482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antiherpesvirus agents. Their targets and therapeutic potential.
    Alrabiah FA; Sacks SL
    Drugs; 1996 Jul; 52(1):17-32. PubMed ID: 8799682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance to virostatic agents in Herpes viruses: mechanism, incidence and clinical significance].
    Reusser P
    Schweiz Med Wochenschr; 1994 Jan; 124(4):152-8. PubMed ID: 8128197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients.
    Fillet AM
    Drugs Aging; 2002; 19(5):343-54. PubMed ID: 12093321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.
    Field AK; Biron KK
    Clin Microbiol Rev; 1994 Jan; 7(1):1-13. PubMed ID: 8118786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of herpesvirus infections in HIV-infected individuals.
    Fletcher CV
    Ann Pharmacother; 1992; 26(7-8):955-62. PubMed ID: 1324033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in herpesvirus therapy.
    Naesens L; De Clercq E
    Herpes; 2001 Mar; 8(1):12-6. PubMed ID: 11867011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA viruses (CMV, EBV, and the herpesviruses).
    Zamora MR
    Semin Respir Crit Care Med; 2011 Aug; 32(4):454-70. PubMed ID: 21858750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.